Published in J Clin Immunol on February 29, 2012
Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology (2013) 1.35
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy. World J Gastroenterol (2014) 0.92
Epithelial toll-like receptor 9 signaling in colorectal inflammation and cancer: clinico-pathogenic aspects. World J Gastroenterol (2013) 0.91
The emerging role of immunotherapy in colorectal cancer. Ann Transl Med (2016) 0.80
Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer. Transl Res (2015) 0.80
Expression of toll-like receptors on human rectal adenocarcinoma cells. Arch Immunol Ther Exp (Warsz) (2014) 0.75
The Protective Role of Type I Interferons in the Gastrointestinal Tract. Front Immunol (2017) 0.75
IFNAR1 is a predictor for overall survival in colorectal cancer and its mRNA expression correlated with IRF7 but not TLR9. Medicine (Baltimore) (2014) 0.75
Decreased expression of TLR7 in gastric cancer tissues and the effects of TLR7 activation on gastric cancer cells. Oncol Lett (2016) 0.75
Toll-like receptor expression pattern: clinical application. J Clin Immunol (2012) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
TLR signaling. Cell Death Differ (2006) 9.24
Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med (2006) 5.10
Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol (2010) 4.07
The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity (2007) 2.44
TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol (2007) 2.03
Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem (2006) 1.88
Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol (2007) 1.68
Study of matrix metalloproteinases and their inhibitors in breast cancer. Br J Cancer (2007) 1.63
Liver expression of matrix metalloproteases and their inhibitors in hepatocellular carcinoma. Dig Liver Dis (2009) 1.50
Cutting edge: Overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J Immunol (2008) 1.44
Toll-like receptors, inflammation and cancer. Semin Cancer Biol (2005) 1.29
Malignant colorectal polyps. World J Gastroenterol (2010) 1.27
Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer. PLoS One (2010) 1.26
TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets (2007) 1.23
Ras-related protein Rab10 facilitates TLR4 signaling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci U S A (2010) 1.22
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother (2010) 1.14
TLR9 blockade inhibits activation of diabetogenic CD8+ T cells and delays autoimmune diabetes. J Immunol (2010) 1.09
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06
Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer. J Physiol Pharmacol (2009) 0.93
Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis. J Gastroenterol (2010) 0.91
JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process? Virol J (2010) 0.86
Does the amount of tagged stool and fluid significantly affect the radiation exposure in low-dose CT colonography performed with an automatic exposure control? Eur Radiol (2010) 0.80
Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer (2010) 0.79
Toll like receptor agonists augment HPV 11 E7-specific T cell responses by modulating monocyte-derived dendritic cells. Arch Dermatol Res (2009) 0.78
Screening and surveillance for colorectal carcinoma. Hematol Oncol Clin North Am (1997) 0.78
Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer (2010) 1.53
Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer (2008) 1.48
Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients. Dig Dis Sci (2012) 1.45
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother (2010) 1.14
Inflammation and cancer. World J Gastrointest Surg (2012) 1.12
Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Histopathology (2013) 1.04
Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer. PLoS One (2012) 1.03
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development. PLoS One (2012) 1.00
Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol (2007) 0.97
Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. Hepatol Res (2013) 0.95
Clinical significance of toll-like receptor 3, 4, and 9 in gastric cancer. J Immunother (2014) 0.90
Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma. Hum Pathol (2009) 0.88
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis. Oncoimmunology (2013) 0.87
CD44s expression in resectable colorectal carcinomas and surrounding mucosa. Cancer Invest (2004) 0.85
Toll-like receptor-4 expression by stromal fibroblasts is associated with poor prognosis in colorectal cancer. J Immunother (2013) 0.85
Expression and clinical signification of cytosolic hyaluronan levels in invasive breast cancer. Breast Cancer Res Treat (2006) 0.84
Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast. Hum Pathol (2010) 0.84
Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat (2006) 0.82
Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node. Eur J Cancer (2012) 0.82
Comparative study of stromal metalloproteases expression in patients with benign hyperplasia and prostate cancer. J Cancer Res Clin Oncol (2010) 0.81
Relationship between arterial vascular calcifications seen on screening mammograms and biochemical markers of endothelial injury. Eur J Radiol (2007) 0.81
Expression and clinical significance of pepsinogen C in epithelial ovarian carcinomas. Eur J Obstet Gynecol Reprod Biol (2002) 0.81
Vulval squamous cell carcinoma arising in localized Darier's disease. Eur J Obstet Gynecol Reprod Biol (2002) 0.81
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas. Histopathology (2010) 0.81
Prognostic value of pre-operative serum CA 15.3 levels in breast cancer. Anticancer Res (2006) 0.81
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas. Int J Clin Oncol (2012) 0.80
Expression of metalloproteases and their inhibitors in primary tumors and in local recurrences after mastectomy for breast cancer. J Cancer Res Clin Oncol (2009) 0.80
Reading virtual slide using web viewers: results of subjective experience with three different solutions. Diagn Pathol (2008) 0.80
Comparative analysis of the expression of metalloproteases and their inhibitors in resected crohn's disease and complicated diverticular disease. Inflamm Bowel Dis (2011) 0.79
Expression and prognostic significance of lysozyme in male breast cancer. Breast Cancer Res (2002) 0.79
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. BMC Cancer (2010) 0.79
Collagenase-3 (MMP-13) expression by inflamed mucosa in inflammatory bowel disease. Scand J Gastroenterol (2006) 0.79
The mammographic appearance of breast carcinomas of invasive ductal type: relationship with clinicopathological parameters, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol (2006) 0.78
Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. Dig Dis Sci (2012) 0.78
Clinical significance of myosin in colorectal cancer. Ann Diagn Pathol (2012) 0.76
alpha(1)-Antichymotrypsin deficiency associated with liver cirrhosis. Pediatr Int (2010) 0.76
CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified. Am J Surg Pathol (2016) 0.76
Analysis of the expression of interleukins, interferon β, and nuclear factor-κ B in prostate cancer and their relationship with biochemical recurrence. J Immunother (2014) 0.76
Collagenase-3 expression by tumor cells and gelatinase B expression by stromal fibroblast-like cells are associated with biochemical recurrence after radical prostatectomy in patients with prostate cancer. World J Urol (2010) 0.76
Significance of the immunohistochemical detection of lymph node micrometastases in stage II colorectal carcinoma. Clin Transl Oncol (2006) 0.76
Automated image analysis in the study of lymphocyte subpopulation in eosinophilic oesophagitis. Diagn Pathol (2014) 0.75
Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA). J Cancer Res Clin Oncol (2005) 0.75
Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids. Ophthalmologica (2004) 0.75
Relationship between breast arterial calcifications seen on screening mammograms and age-related macular degeneration. Acta Ophthalmol (2014) 0.75